OnCore® Streamlines Clinical Trial Registration with Built-in Automated Functionality

MADISON, Wis., Oct. 24, 2012 /PRNewswire/ -- Forte Research Systems, Inc., a leading developer of specialized clinical trial management systems (CTMS), is pleased to unveil the latest enhancement to the OnCore^® clinical research management system: a submission console for directly registering clinical trials with the NCI's Clinical Trials Reporting Program (CTRP).

(Logo: http://photos.prnewswire.com/prnh/20101115/CG02078LOGO)

The OnCore system, the nation's most widely adopted enterprise-class clinical research management system among academic medical centers and cancer centers, now allows centers to submit applicable cancer-related clinical trials to the NCI registry with just the click of a button — saving significant time and effort, and ultimately easing the burden of compliance with stringent regulations.

Responding to Industry Need

"There is always a desire on the part of research institutions to avoid duplicate data entry, and a lot of the required trial data for CTRP is already entered into OnCore," explained Tony O'Hare, Co-Founder, Vice President of Engineering, & Chief Collaboration Officer at Forte. "The simplified process leads to greater ease in complying with registration requirements. It made absolute sense to meet this need."

The collaboration between Forte, OnCore users, and the NCI was initiated when the centers requested the ability to register clinical trials directly from within the CTMS.

"Trial registration is an essential process of clinical research. We saw an opportunity to create greater efficiencies by integrating with CTRP," said Srini Kalluri, Founder, CEO, and Chief Customer Officer at Forte. "We now provide the best solution for this available. This is a significant development that will transform current operations and lead to simpler compliance with registration requirements."  

About Forte Research Systems, Inc.

Forte Research Systems, Inc. develops specialized clinical trial management software systems (CTMS). Mid-sized to large academic medical centers, research hospitals, and cancer centers rely on Forte's OnCore system, which boasts a broad technological footprint comprised of CTMS, EDC, biospecimen management, and patient-oriented research management functionality for organizations with robust portfolios of clinical trials. Investigator sites, research groups, and investigator site networks value the flexibility and small footprint of the Allegro^® family of cloud-based clinical trial management systems.

SOURCE Forte Research Systems, Inc.